Development and validation of a liquid chromatography–tandem mass spectrometry analytical method for the therapeutic drug monitoring of eight novel anticancer drugs
M. Herbrink*, N. de Vries, H. Rosing, A. D.R. Huitema, B. Nuijen, J. H.M. Schellens, J. H. Beijnen
Research output: Contribution to journal › Article › Academic › peer-review
2Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Development and validation of a liquid chromatography–tandem mass spectrometry analytical method for the therapeutic drug monitoring of eight novel anticancer drugs'. Together they form a unique fingerprint.